2022 American Transplant Congress
Pediatric Liver Transplant Factors That Influence Tacrolimus Absorption
1Children's Hospital Colorado, Aurora, CO, 2University of Colorado, Aurora, CO
*Purpose: The aim of this study was to investigate the association between various pediatric recipient characteristics at time of liver transplant and FK506 absorption 6…2022 American Transplant Congress
Impact of Biliary Reconstruction on Tacrolimus Absorption in Pediatric Liver Transplant
1Children's Hospital Colorado, Aurora, CO, 2University of Colorado, Aurora, CO
*Purpose: Tacrolimus (FK506) oral bioavailability in pediatric liver transplant recipients (LTR) is poor. Enteral FK506 is primarily absorbed in the small intestine and subject to…2021 American Transplant Congress
Comparison of Outcomes of Living Donor Liver Transplantation for Biliary Atresia Patients with and without Kasai Portoenterostomy
*Purpose: We evaluated 10 year outcomes and the potential predictors of outcomes after living donor liver transplant (LT) for biliary atresia (BA) patients with and…2021 American Transplant Congress
Portal Vein Challenges in Pediatric Liver Transplantation: The Utility of Interposition Grafts as an Acceptable Management Strategy
*Purpose: To examine our single center experience in the operative management of pediatric liver transplantation (LT) patients with challenging portal vein (PV) anomalies.*Methods: We retrospectively…2020 American Transplant Congress
Waitlist Mortality in Children with Biliary Atresia: A Competing Risks Analysis
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Biliary atresia (BA) is the most common indication for liver transplant (LT) in children. The current PELD allocation algorithm does not accurately reflect the…2020 American Transplant Congress
New Concept of Liver Transplatation in Pediatric Patient – Up Side Down Metod
Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
*Purpose: Liver transplantation (LTx) in pediatrics has become an accepted modality for treatment in end-stage liver disease and irreversible acute liver failure. Left lateral segment…2020 American Transplant Congress
Pediatric Liver Transplantation for Metabolic Liver Diseases versus Biliary Atresia: Single Center Experience
MedStar Georgetown Transplant Institute, Georgetown University Hospital, Washington, DC
*Purpose: The main indication for LT in children has been biliary atresia (BA). Recent advances in surgical management and the development of new immunosuppressants have…2019 American Transplant Congress
Biliary Atresia Patients Receiving Liver Transplantation Reflect Changing Birth Demographics in the United States between 1987-2018
Childrens Hospital of Pittsburgh of UPMC, Pittsburgh, PA
*Purpose: To review the multi-center US experience with liver transplantation (LT) for Biliary Atresia (BA)*Methods: We reviewed LT outcomes in children with BA in the…2019 American Transplant Congress
Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience
Stanford University Medical Center, Palo Alto, CA
*Purpose: Liver transplantation (LT) for acute and chronic end-stage-liver-disease is a well-accepted therapy in pediatrics. However, for children with metabolic disorders (MD) without intrinsic liver…2018 American Transplant Congress
Comparison of No Kasai Portoenterstomy to Failed Kasai: Analysis of UNOS Database
Texas Children's Hospital/Baylor College of Medicine, Houston.
IntroductionInfants with biliary atresia (BA) identified “later” (typically after 90 days of life) present a management challenge, as late Kasai portoenterostomy (KP) has high failure…
American Transplant Congress abstracts